Strategic-Technological Analysis of RealNose
29 pages · PDF · 11 August 2025 · Licensed single-user copy, watermarked to the buyer
Tactical Advanced Sensors, Radar, Lidar & Optronics Biotechnology, Human Enhancement & MedTech
€299 excl. VAT — EU VAT calculated at checkout (VAT ID accepted for reverse charge); invoice issued after payment
One click to Stripe — guest checkout, no account. Your download appears on the confirmation page and arrives by e-mail right after payment (link valid 72 hours, up to 5 downloads).
About this report
In an era when European security and technology agendas increasingly converge, an unlikely innovator is capturing attention with a breakthrough inspired by biology. RealNose is a startup developing an “artificial nose” – an electronic olfaction sensor capable of sniffing out minute chemical traces much like a trained dog.
Born from cutting-edge research at MIT and now advancing in the defense arena, RealNose offers a tantalizing glimpse into how biotechnology and AI might bolster Europe’s security toolkit.
Key questions this report answers
- How does RealNose's electronic olfaction sensor detect minute chemical traces, much like a trained dog?
- How did the technology move from MIT research toward the defence arena, and how mature is it?
- Which security applications could an 'artificial nose' serve in Europe's toolkit?
- What do the report's IP, readiness and strategic-indicator analyses show?
Inside this report
- Executive Summary
- 1. Corporate Identity & Legal Structure
- 2. Strategic Business Profile
- 3. Technology Portfolio Mapping
- 4. Technology Readiness Assessment
- 5. European Strategic Program Participation
- 6. Academic & Research Origins
- 7. Dual-Use Applications & European Market Strategy
- 8. Strategic Partnerships & European Industrial Alliances
- 9. European Market Focus & Operational Domains
- 10. Intellectual Property & European Innovation Assets
- 11. Leadership & European Technical Expertise
- 12. Strategic Indicators & European Innovation Metrics
Who it's for
Investors screening RealNose, competitors and partners assessing their position, and analysts who need a sourced, structured account of the entity and its technology.
Methodology & sources
DFM reports are built from primary and official sources — TED procurement notices, CORDIS and the EU Funding & Tenders Portal, EIB operations, the NATO Innovation Fund portfolio, SIPRI data, official budget documents and company disclosures — read together with the underlying legal texts. Sources are cited in the document; the report reflects them as of its publication date (11 August 2025).
Format & delivery
29-page PDF, watermarked to you (name, e-mail, order number on every page). Delivered immediately after checkout on the confirmation page and by e-mail; the personal link is valid for 72 hours and up to 5 downloads (re-issued on request). Guest checkout — no account required. Single-user licence: see the Terms of Sale.
The full analysis, not the summary
The public briefing linked above tells you what this report found; the report itself shows the full evidence and reasoning behind it, section by section. It is the complete, dated document from the DFM research desk — sources cited, delivered as a licensed PDF you can keep and cite in your own work.
Related on DFM
More Tactical reports · Advanced Sensors, Radar, Lidar & Optronics · Biotechnology, Human Enhancement & MedTech · Free summary of this report · All reports
Prefer unlimited access?
Prefer unlimited access? Every report like this is included in the DFM Analysis subscription. See plans →